318 related articles for article (PubMed ID: 29980610)
1. Mesenchymal Stromal Cells Stimulate the Proliferation and IL-22 Production of Group 3 Innate Lymphoid Cells.
van Hoeven V; Munneke JM; Cornelissen AS; Omar SZ; Spruit MJ; Kleijer M; Bernink JH; Blom B; Voermans C; Hazenberg MD
J Immunol; 2018 Aug; 201(4):1165-1173. PubMed ID: 29980610
[TBL] [Abstract][Full Text] [Related]
2. The Therapeutic Effect of ICAM-1-Overexpressing Mesenchymal Stem Cells on Acute Graft-Versus-Host Disease.
Tang B; Li X; Liu Y; Chen X; Li X; Chu Y; Zhu H; Liu W; Xu F; Zhou F; Zhang Y
Cell Physiol Biochem; 2018; 46(6):2624-2635. PubMed ID: 29763906
[TBL] [Abstract][Full Text] [Related]
3. Efficient
Bennstein SB; Weinhold S; Degistirici Ö; Oostendorp RAJ; Raba K; Kögler G; Meisel R; Walter L; Uhrberg M
Front Immunol; 2021; 12():797432. PubMed ID: 35003122
[TBL] [Abstract][Full Text] [Related]
4. Inducible Costimulator Gene-Transduced Bone Marrow-Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in Mouse Models.
Yang D; Wang LP; Zhou H; Cheng H; Bao XC; Xu S; Zhang WP; Wang JM
Cell Transplant; 2015; 24(9):1717-31. PubMed ID: 25203502
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal Stromal Cell (MSC)-Derived Combination of CXCL5 and Anti-CCL24 Is Synergistic and Superior to MSC and Cyclosporine for the Treatment of Graft-versus-Host Disease.
Fan X; Guo D; Cheung AMS; Poon ZY; Yap CS; Goh SE; Guo D; Li H; Bari S; Li S; Lim KH; Hwang WYK
Biol Blood Marrow Transplant; 2018 Oct; 24(10):1971-1980. PubMed ID: 29883796
[TBL] [Abstract][Full Text] [Related]
6. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease.
Yañez R; Lamana ML; García-Castro J; Colmenero I; Ramírez M; Bueren JA
Stem Cells; 2006 Nov; 24(11):2582-91. PubMed ID: 16873762
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Mesenchymal Stromal Cells From Different Origins for the Treatment of Graft-vs.-Host-Disease in a Humanized Mouse Model.
Grégoire C; Ritacco C; Hannon M; Seidel L; Delens L; Belle L; Dubois S; Vériter S; Lechanteur C; Briquet A; Servais S; Ehx G; Beguin Y; Baron F
Front Immunol; 2019; 10():619. PubMed ID: 31001253
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation.
Zhao K; Lou R; Huang F; Peng Y; Jiang Z; Huang K; Wu X; Zhang Y; Fan Z; Zhou H; Liu C; Xiao Y; Sun J; Li Y; Xiang P; Liu Q
Biol Blood Marrow Transplant; 2015 Jan; 21(1):97-104. PubMed ID: 25300866
[TBL] [Abstract][Full Text] [Related]
9. Human CD40 ligand-expressing type 3 innate lymphoid cells induce IL-10-producing immature transitional regulatory B cells.
Komlósi ZI; Kovács N; van de Veen W; Kirsch AI; Fahrner HB; Wawrzyniak M; Rebane A; Stanic B; Palomares O; Rückert B; Menz G; Akdis M; Losonczy G; Akdis CA
J Allergy Clin Immunol; 2018 Jul; 142(1):178-194.e11. PubMed ID: 28939410
[TBL] [Abstract][Full Text] [Related]
10. Mouse bone marrow-derived mesenchymal stem cells inhibit leukemia/lymphoma cell proliferation in vitro and in a mouse model of allogeneic bone marrow transplant.
Song N; Gao L; Qiu H; Huang C; Cheng H; Zhou H; Lv S; Chen L; Wang J
Int J Mol Med; 2015 Jul; 36(1):139-49. PubMed ID: 25901937
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow-derived conventional, but not cloned, mesenchymal stem cells suppress lymphocyte proliferation and prevent graft-versus-host disease in rats.
Kitazawa Y; Li XK; Xie L; Zhu P; Kimura H; Takahara S
Cell Transplant; 2012; 21(2-3):581-90. PubMed ID: 22793067
[TBL] [Abstract][Full Text] [Related]
12. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.
Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG
Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stromal/stem cells promote intestinal epithelium regeneration after chemotherapy-induced damage.
Yetkin-Arik B; Jansen SA; Varderidou-Minasian S; Westendorp B; Skarp KP; Altelaar M; Lindemans CA; Lorenowicz MJ
Stem Cell Res Ther; 2024 Apr; 15(1):125. PubMed ID: 38679715
[TBL] [Abstract][Full Text] [Related]
14. [Mesenchymal stem cells for treatment of graft-versus-host disease].
Najima Y
Rinsho Ketsueki; 2017; 58(12):2440-2449. PubMed ID: 29332881
[TBL] [Abstract][Full Text] [Related]
15. Loss of thymic innate lymphoid cells leads to impaired thymopoiesis in experimental graft-versus-host disease.
Dudakov JA; Mertelsmann AM; O'Connor MH; Jenq RR; Velardi E; Young LF; Smith OM; Boyd RL; van den Brink MRM; Hanash AM
Blood; 2017 Aug; 130(7):933-942. PubMed ID: 28607133
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells attenuate rat graft-versus-host disease.
Fujino M; Zhu P; Kitazawa Y; Chen JM; Zhuang J; Li XK
Methods Mol Biol; 2014; 1213():341-53. PubMed ID: 25173396
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stromal cells for graft-versus-host disease : basic aspects and clinical outcomes.
Sato K; Ozaki K; Mori M; Muroi K; Ozawa K
J Clin Exp Hematop; 2010; 50(2):79-89. PubMed ID: 21123965
[TBL] [Abstract][Full Text] [Related]
18. Effects of bone marrow mesenchymal stem cells on hematopoietic recovery and acute graft-versus-host disease in murine allogeneic umbilical cord blood transplantation model.
Li ZY; Wang CQ; Lu G; Pan XY; Xu KL
Cell Biochem Biophys; 2014 Sep; 70(1):115-22. PubMed ID: 24696072
[TBL] [Abstract][Full Text] [Related]
19. Extracellular Vesicles Released from Human Umbilical Cord-Derived Mesenchymal Stromal Cells Prevent Life-Threatening Acute Graft-Versus-Host Disease in a Mouse Model of Allogeneic Hematopoietic Stem Cell Transplantation.
Wang L; Gu Z; Zhao X; Yang N; Wang F; Deng A; Zhao S; Luo L; Wei H; Guan L; Gao Z; Li Y; Wang L; Liu D; Gao C
Stem Cells Dev; 2016 Dec; 25(24):1874-1883. PubMed ID: 27649744
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cell adhesion to cardiac microvascular endothelium: activators and mechanisms.
Segers VF; Van Riet I; Andries LJ; Lemmens K; Demolder MJ; De Becker AJ; Kockx MM; De Keulenaer GW
Am J Physiol Heart Circ Physiol; 2006 Apr; 290(4):H1370-7. PubMed ID: 16243916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
